Caisse DE Depot ET Placement DU Quebec Grows Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Caisse DE Depot ET Placement DU Quebec increased its stake in Intuitive Surgical by 9.8%, owning roughly 0.10% of the company, valued at about $182.9 million after acquiring an additional 32,950 shares.
• Analyst ratings for Intuitive Surgical show a consensus of "Moderate Buy" with a price target averaging around $595.95, with thirteen analysts recommending a buy.
• Insiders at Intuitive Surgical, including CEO Gary S. Guthart, have sold significant shares recently, leading to a decrease in their personal ownership stakes.

Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 369,289 shares of the medical equipment provider's stock after purchasing an additional 32,950 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned 0.10% of Intuitive Surgical worth $182,898,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Apexium Financial LP lifted its holdings in shares of Intuitive Surgical by 13.5% during the first quarter. Apexium Financial LP now owns 472 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 56 shares in the last quarter. Mirova lifted its holdings in shares of Intuitive Surgical by 4.1% during the first quarter. Mirova now owns 14,267 shares of the medical equipment provider's stock valued at $7,066,000 after purchasing an additional 564 shares in the last quarter. Synovus Financial Corp lifted its holdings in shares of Intuitive Surgical by 36.9% during the first quarter. Synovus Financial Corp now owns 3,492 shares of the medical equipment provider's stock valued at $1,729,000 after purchasing an additional 941 shares in the last quarter. ICONIQ Capital LLC lifted its holdings in shares of Intuitive Surgical by 16.3% during the first quarter. ICONIQ Capital LLC now owns 1,930 shares of the medical equipment provider's stock valued at $956,000 after purchasing an additional 270 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC lifted its holdings in shares of Intuitive Surgical by 125.4% during the first quarter. Campbell & CO Investment Adviser LLC now owns 3,778 shares of the medical equipment provider's stock valued at $1,871,000 after purchasing an additional 2,102 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $2.69 during mid-day trading on Thursday, reaching $473.84. The stock had a trading volume of 1,548,672 shares, compared to its average volume of 1,988,124. The business has a fifty day moving average of $501.89 and a 200 day moving average of $519.66. The firm has a market cap of $169.86 billion, a price-to-earnings ratio of 66.09, a PEG ratio of 4.94 and a beta of 1.59. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue was up 21.4% on a year-over-year basis. During the same period last year, the firm earned $1.78 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other news, insider Gary S. Guthart sold 2,800 shares of the firm's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock worth $7,896,972 in the last three months. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ISRG shares. UBS Group upped their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Wells Fargo & Company upped their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Piper Sandler reissued an "overweight" rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.